National Comprehensive Cancer Network

About NCCN

NCCN News

NCCN welcomes the opportunity to work with reporters on all cancer-related topics. NCCN offers members of the media access to scientific and medical experts, news releases, background research, and much more. We can also help connect press with investigators and clinicians who can discuss research, treatment and issues related to cancer through coordination with media contacts at NCCN Member Institutions.

For news, interviews, photo requests or the most current information and resources available, please contact:

Note: NCCN neither reviews nor approves press releases announcing the inclusion of tests, agents, and/or therapies listed within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). For any additional commercial use of NCCN Content in promotional and educational materials, NCCN requires a license and review of content.

Newsroom

Press kits, media advisories, and information on upcoming events.

Press Releases

• New Research in JNCCN Evaluates Cost-Effectiveness of Olaparib, a PARP Inhibitor, for Metastatic Pancreatic Cancer  (11/12/2020)
• NCCN Announces Beth Gaffney, MBA, as New Vice President of U.S. and Global Business Development  (10/27/2020)
• NCCN Oncology Research Program and Puma Biotechnology, Inc. Collaborate to Study Neratinib in Various Cancers  (10/15/2020)
• JNCCN: New Research Finds Low Bone Health Testing Rates after Prostate Cancer Treatment   (10/07/2020)

View more >

Health Care Policy News

View more >

NCCN eBulletin Newsletter

November 23, 2020 | Volume 12 Issue 24

• NCCN Flash Updates: NCCN Templates^® Updated for Head and Neck Cancers
• Now Available! Know What Your Doctors Know: Metastatic Breast Cancer Recorded Videos
• Earn Continuing Education Credits! Interactive Online Case Study Designed to Help Participants Identify Clinical Challenges in Managing Patients with Lymphoma
• NCCN Patient Advocacy Summit: Delivering Value for Patients Across the Oncology Ecosystem

November 9, 2020 | Volume 12 Issue 23

• NCCN Flash Updates: NCCN Guidelines^® and NCCN Compendium^® Updated for Testicular Cancer
• NCCN Guidelines for Patients: Prostate Cancer is Now Available for Early Stage and Advanced Stage
• New Webinar Series on NCCN Guidelines for Pediatric Cancers Starting with Pediatric Hodgkin Lymphoma
• View Recorded Presentations from the NCCN Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™

View more >

NCCN in the News

• cancernetwork: Maintenance Olaparib May Be Cost-Effective for BRCA-Mutated Metastatic Pancreatic Cancer  (11/19/2020)
• Medscape: Olaparib in BRCA+ Pancreatic Cancer: Cost-effectiveness Analyzed   (11/19/2020)
• TARGETED ONCOLOGY: Paradigm Pivots in Neoadjuvant Direction: Expert Insights on World Pancreatic Cancer Day  (11/18/2020)
• ITPro: Outcomes4Me raises $4.7M for its AI-powered breast cancer care app  (11/18/2020)

View more >

NCCN Member Institutions in the News

• Medicaid Expansion Linked to Lower Mortality Rates for Three Major Types of Cancer  (11/05/2020)
• Active Surveillance Safe for African Americans with Low-Risk Prostate Cancer   (11/03/2020)
• Immunotherapy Side Effect Could Be a Positive Sign for Kidney Cancer Patients  (11/02/2020)
• Roswell Park Sees Suggestion of Benefit in First Clinical Trial to Combine Beta-Blocker and Checkpoint Inhibitor  (10/30/2020)

View more >